Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin for Brugada Syndrome
NCT07146880Phase 2Not yet recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Sep 2025
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of empagliflozin in Brugada syndrome, sponsored by National Taiwan University Hospital. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
empagliflozin
03
Conditions
Brugada syndrome
Beyond the preview
Go deeper on NCT07146880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07146880.